Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 2/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.30 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8610348 | 0.84 | AKR1B1 (0.36) | CA9TYMSPARP1KMT2A | |
| SCHEMBL8611233 | 0.81 | CYP19A1 (0.39) | CYP19A1CA9TYMS | |
| SCHEMBL8616201 | 0.81 | KDM4E (0.39) | TDP2KDM4EGAA | |
| SCHEMBL8613975 | 0.75 | KDM4E (0.30) | CA9KDM4EGAAAPEX1KMT2A | |
| SCHEMBL9140465 | 0.75 | CA9 (0.40) | CYP19A1CA9TYMSPARP1TDP2 | |
| SCHEMBL8610304 | 0.69 | ADRA2A (0.40) | CYP19A1 | |
| SCHEMBL27463810 | 0.66 | CA9 (0.41) | CA9TYMSPARP1TDP2CRBN | |
| SCHEMBL8611882 | 0.66 | ALDH1A1 (0.39) | CA9TDP2KMT2ATDP1 | |
| SCHEMBL8614549 | 0.66 | AKR1B1 (0.34) | TYMSPARP1 | |
| SCHEMBL1709821 | 0.63 | CA9 (0.53) | CYP19A1CA9TDP2KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0618906-B1 | SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR PREPARATION AND USE | JUVANTIA PHARMA LTD OY (FI) | 1998-04-22 | — | — | EP | disclosed |
| US-5498623-A | MULTISTAGE REACTION FOR HALOGENATION OF COMPOUNDS, NITRATION, REDUCTION AND CONVERSION TO DIAZONIUM SALT THEN HALOGENATION FOR COGNITIVE DISORDERS | ORION-YHTYMA OY (FI) | 1996-03-12 | — | — | US | disclosed |